$40M asset forfeiture request for web drug dealers

19 November 2007

Six US and Puerto Rican citizens have been charged with selling controlled substances and prescribed drugs via an Internet pharmacy, as well as money-laundering, according to a statement by the US Department of Justice. The accused are alleged to have conspired to distribute, illegally, more than 12 million painkillers and other prescribable products by the use of 246,000 fake prescriptions. One of the charges claims that minors were employed in the distribution process. The US District Court in Cedar Rapids, Iowa, is the location of the filing of prosecution documents, although most of the defendants are from Florida.

The distribution network operated from the www.BuyMeds.com web site and prosecutors have declared their intention of securing up to $40.0 million in forfeited assets. A court hearing is due before the end of November.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight